The health-data company could see a pop in its stock price, but there are plenty of warning signs
Related stories
Hollywood recasts tech tycoons as bad billionaires
BoE scrutinises Barclays over claim traders misrepresented private credit exposure
Americans are unhappy. How will they vote in the midterms?
Anthropic says it will commit 5% of its shares to 'public benefit fund'
China's economic growth picks up as AI boom boosts exports
China’s economy expands 4.5% in third quarter